Cambridge, MA · Founded 2017 · Privately Held (backing)
Developer of a cell engineering platform designed to offer healthy and functional cells. Kytopen is based in Cambridge, MA and was founded in 2017. Its last reported valuation was $47 million in Sep 2024. It has raised $52.9 million across 5 recorded rounds; the latest was a $7.1 million early-stage round in Feb 2025.
Last reported valuation
$47.0M
Oct 2026
Priced at
—
Total raised
$52.9M
Last round
Early Stage VC
Feb 2025
Team — not yet on record
No current team members for Kytopen are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kytopen with a free account
·The complete investor list: 16 names
·Watch Kytopen: the Monday email on marks, rounds and moves
